[HTML][HTML] Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns… - American heart …, 2013 - Elsevier
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns, KH Kuck… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

[PDF][PDF] Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns… - American Heart …, 2013 - cyberleninka.org
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns… - American Heart …, 2013 - europepmc.org
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

[PDF][PDF] Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns, KH Kuck… - 2013 - researchgate.net
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

[PDF][PDF] Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns, KH Kuck… - 2013 - academia.edu
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm, HJ Crijns… - American Heart …, 2013 - infona.pl
Even on optimal therapy including anticoagulation and rate control, major cardiovascular
complications (stroke, cardiovascular death, and acute heart failure) are common in patients …

Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm… - American Heart …, 2013 - cris.maastrichtuniversity.nl
Background Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm… - American Heart …, 2013 - research.birmingham.ac.uk
BACKGROUND: Even on optimal therapy including anticoagulation and rate control, major
cardiovascular complications (stroke, cardiovascular death, and acute heart failure) are …

[引用][C] Improving outcomes in patients with atrial fibrillation: Rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial

P Kirchhof, G Breithardt, AJ Camm… - The American Heart …, 2013 - Elsevier Limited